Raine To Lead UK MHRA Ahead Of Permanent Head Announcement
June Raine has agreed to lead the Medicines and Healthcare products Regulatory Agency temporarily after the agency’s incumbent chief executive steps down in September.
You may also be interested in...
Sir Andrew Dillon is leaving his role as CEO of England’s health technology assessment body after 20 years.
Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.
John Wilkinson talks to Medtech Insight about his legacy, Brexit issues and how he sees the UK regulatory system evolving when he leaves in October this year, after seven years as head of devices at the MHRA.